Phio Pharmaceuticals Corp (PHIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 18,070 | 20,509 | 24,107 | 26,579 | 29,475 |
| TOTAL | $19,688 | $21,667 | $24,727 | $27,450 | $31,155 |
| Non-Current Assets | |||||
| PPE Net | 206 | 215 | 133 | 153 | 142 |
| Other Non-Current Assets | 250 | 280 | 310 | 340 | 360 |
| TOTAL | $456 | $495 | $443 | $493 | $502 |
| Total Assets | $20,144 | $22,162 | $25,170 | $27,943 | $31,657 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,148 | 329 | 283 | 322 | 348 |
| Accrued Expenses | 1,759 | 2,117 | 2,660 | 2,061 | 2,110 |
| TOTAL | $3,037 | $2,573 | $3,068 | $2,495 | $2,578 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 104 | 138 | 170 | 202 | 234 |
| TOTAL | $104 | $138 | $170 | $202 | $234 |
| Total Liabilities | $3,141 | $2,711 | $3,238 | $2,697 | $2,812 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 126 | 126 | 125 | 125 | 125 |
| Common Shares | 1 | 1 | N/A | 1 | 1 |
| Retained earnings | -122,073 | -119,542 | -116,900 | -113,449 | -109,707 |
| TOTAL | $17,003 | $19,451 | $21,932 | $25,246 | $28,845 |
| Total Liabilities And Equity | $20,144 | $22,162 | $25,170 | $27,943 | $31,657 |